Clinical trial
Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy
NCT07289178 is registered in ClinicalTrials.gov with First Affiliated Hospital of Kunming Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy
- Lead sponsor
- First Affiliated Hospital of Kunming Medical University
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- December 30, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic post-surgical pain, liposomal bupivacaine, postoperative hyperalgesia, radical mastectomy surgery, serratus plane block